| consensus statements on therapeutic drug monitoring of anti‐tumour necrosis factor therapy in inflammatory bowel diseases N Mitrev, N Vande Casteele, CH Seow, JM Andrews, SJ Connor, ... Alimentary pharmacology & therapeutics 46 (11-12), 1037-1053, 2017 | 278 | 2017 |
| Pruritus ani SA Siddiqi, AM Siddika Keighley & Williams' Surgery of the Anus, Rectum and Colon, Fourth Edition …, 2018 | 91 | 2018 |
| Therapeutic drug monitoring of biologics during induction to prevent primary non-response MP Sparrow, K Papamichael, MG Ward, P Riviere, D Laharie, S Paul, ... Journal of Crohn's and Colitis 14 (4), 542-556, 2020 | 75 | 2020 |
| Infliximab and adalimumab drug levels in Crohn's disease: contrasting associations with disease activity and influencing factors MG Ward, B Warner, N Unsworth, SW Chuah, C Brownclarke, S Shieh, ... Alimentary Pharmacology & Therapeutics 46 (2), 150-161, 2017 | 71 | 2017 |
| Prevalence and Risk Factors for Functional Vitamin B12 Deficiency in Patients with Crohn's Disease MG Ward, VC Kariyawasam, SB Mogan, KV Patel, M Pantelidou, ... Inflammatory bowel diseases 21 (12), 2839-2847, 2015 | 64 | 2015 |
| determination of the therapeutic range for therapeutic drug monitoring of adalimumab and infliximab in patients with inflammatory bowel disease DJ Gibson, MG Ward, C Rentsch, AB Friedman, KM Taylor, MP Sparrow, ... Alimentary pharmacology & therapeutics 51 (6), 612-628, 2020 | 63 | 2020 |
| Therapeutic drug monitoring of vedolizumab in inflammatory bowel disease: current data and future directions MG Ward, MP Sparrow, X Roblin Therapeutic advances in gastroenterology 11, 1756284818772786, 2018 | 57 | 2018 |
| Intra‐patient variability in adalimumab drug levels within and between cycles in Crohn's disease MG Ward, PA Thwaites, L Beswick, J Hogg, G Rosella, ... Alimentary Pharmacology & Therapeutics 45 (8), 1135-1145, 2017 | 49 | 2017 |
| IBD Sydney Organisation and the Australian Inflammatory Bowel Diseases Consensus Working Group. Review article: consensus statements on therapeutic drug monitoring of anti … N Mitrev, N Vande Casteele, CH Seow, JM Andrews, SJ Connor, ... Aliment Pharmacol Ther 46 (11-12), 1037-1053, 2017 | 49 | 2017 |
| Infliximab, adalimumab and vedolizumab concentrations across pregnancy and vedolizumab concentrations in infants following intrauterine exposure E Flanagan, PR Gibson, EK Wright, GT Moore, MP Sparrow, W Connell, ... Alimentary Pharmacology & Therapeutics 52 (10), 1551-1562, 2020 | 45 | 2020 |
| Thioguanine in inflammatory bowel disease: long-term efficacy and safety MG Ward, KV Patel, VC Kariyawasam, R Goel, B Warner, TR Elliott, ... United European Gastroenterology Journal 5 (4), 563-570, 2017 | 36 | 2017 |
| Evaluation of the utility of the Vigileo FloTrac™, LiDCO™, USCOM and CardioQ™ to detect hypovolaemia in conscious volunteers: a proof of concept study E O'Loughlin, M Ward, A Crossley, R Hughes, AP Bremner, T Corcoran Anaesthesia 70 (2), 142-149, 2015 | 31 | 2015 |
| Thiopurines dosed to a therapeutic 6-thioguanine level in combination with adalimumab are more effective than subtherapeutic thiopurine-based combination therapy or adalimumab … VC Kariyawasam, MG Ward, PA Blaker, KV Patel, R Goel, JD Sanderson, ... Inflammatory Bowel Diseases 23 (9), 1555-1565, 2017 | 27 | 2017 |
| Is there a role for thioguanine therapy in IBD in 2017 and beyond? KM Taylor, MG Ward, PA Blaker, MP Sparrow Expert Review of Gastroenterology & Hepatology 11 (5), 473-486, 2017 | 22 | 2017 |
| Practical management of inflammatory bowel disease patients during the COVID‐19 pandemic: expert commentary from the Gastroenterological Society of Australia Inflammatory Bowel … AA Aysha, C Rentsch, R Prentice, D Johnson, RV Bryant, MG Ward, ... Internal Medicine Journal 50 (7), 798-804, 2020 | 19 | 2020 |
| Therapeutic drug monitoring of subcutaneous infliximab in inflammatory bowel disease—understanding pharmacokinetics and exposure response relationships in a new era of … RD Little, MG Ward, E Wright, AJ Jois, A Boussioutas, GL Hold, ... Journal of Clinical Medicine 11 (20), 6173, 2022 | 16 | 2022 |
| The potential value of faecal lactoferrin as a screening test in hospitalized patients with diarrhoea DR Van Langenberg, RB Gearry, HL Wong, M Ward, PR Gibson Internal medicine journal 40 (12), 819-827, 2010 | 16 | 2010 |
| Circulating tumour cell enumeration does not correlate with Miller–Payne grade in a cohort of breast cancer patients undergoing neoadjuvant chemotherapy SA O’Toole, C Spillane, Y Huang, MC Fitzgerald, B Ffrench, B Mohamed, ... Breast Cancer Research and Treatment 181, 571-580, 2020 | 15 | 2020 |
| A virtual clinic increases anti‐TNF dose intensification success via a treat‐to‐target approach compared with standard outpatient care in Crohn’s disease A Srinivasan, DR van Langenberg, RD Little, MP Sparrow, P De Cruz, ... Alimentary pharmacology & therapeutics 51 (12), 1342-1352, 2020 | 15 | 2020 |
| The evaluation of anaesthesia-related information on the Internet TB Corcoran, M Ward, K Jarosz, SA Schug Anaesthesia and intensive care 37 (1), 79-84, 2009 | 13 | 2009 |